Skip to content

Role of Trivruttadi churna and Hingwadi churna in Heart disease

A randomized comparative clinical Study to evaluate the efficacy of Trivruttadi churna and Hingwadi churna in the management of Kaphaja Hridroga with special reference to Chronic Stable Angina Pectoris - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069286
Enrollment
30
Registered
2024-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I209- Angina pectoris, unspecified

Interventions

None listed

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with evidence of chronic stable angina pectoris including cases with controlled hypertension and controlled type 2 diabetes mellitus without complications and not on insulin. Any patient on conventional treatment for at least one month and having symptoms of chronic stable angina pectoris.

Exclusion criteria

Exclusion criteria: Patients with the history of unstable angina pectoris, acute myocardial infarction, severe valvular defects, congenital heart disease, pericarditis, arrhythmia, congestive heart failure. Patients with the history of extra cardiac ailments like renal failure, uncontrolled hypertension, uncontrolled type 2 diabetes mellitus with or without complications, type 1 diabetes mellitus. Patients with ejection fraction less than 40%. Chronic alcoholics, pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Changes present in the CTMT of registered patients with symptoms of chronic stable angina pectoris.Timepoint: At baseline and at the end of 60 days of treatment.

Secondary

MeasureTime frame
1. Changes present in the ECG and 2D echocardiography of registered patients with symptoms of chronic stable angina pectoris.2. Changes present in the symptoms of Kaphaja Hridroga and chronic stable angina pectoris.Timepoint: At baseline and at the end of 60 days of treatment.

Countries

India

Contacts

Public ContactProfessor Udai Raj Saroj

National Institute of Ayurveda, Jaipur

ursarojayu@gmail.com9983341119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026